Analysts fell to the sidelines weighing in on and AngioDynamics (ANGO) with neutral ratings, indicating that the experts are neither bullish nor bearish on the stocks.
AngioDynamics (ANGO)
In a report issued on April 18, Jayson Bedford from Raymond James maintained a Hold rating on AngioDynamics. The company’s shares closed last Wednesday at $14.38.
According to TipRanks.com, Bedford is a 5-star analyst with an average return of 15.1% and a 69.1% success rate. Bedford covers the Healthcare sector, focusing on stocks such as Cardiovascular Systems, Merit Medical Systems, and Edwards Lifesciences.
Currently, the analyst consensus on AngioDynamics is a Moderate Buy with an average price target of $16.00, implying a 6.2% upside from current levels. In a report issued on October 4, Craig-Hallum also reiterated a Hold rating on the stock with a $17.00 price target.
See today’s analyst top recommended stocks >>
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
